methylprednisolone has been researched along with celecoxib in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bachmeyer, C; Charoud, A; Habki, R; Mofredj, A; Vermeulen, C | 1 |
| Asadollahzade, A; Esmaeili, S; Farzan, A; Hamidi Madani, A; Kazemzadeh, M; Pourreza, F; Shakiba, M | 1 |
| Hansen, TB; Munk, S; Rytter, S; Stilling, M | 1 |
1 review(s) available for methylprednisolone and celecoxib
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for methylprednisolone and celecoxib
| Article | Year |
|---|---|
Randomized controlled trial of the efficacy of isosorbide-SR addition to current treatment in medical expulsive therapy for ureteral calculi.
Topics: Adult; Celecoxib; Delayed-Action Preparations; Drug Therapy, Combination; Female; Humans; Isosorbide; Male; Methylprednisolone; Middle Aged; Parasympatholytics; Prospective Studies; Pyrazoles; Sulfonamides; Treatment Outcome; Ureteral Calculi | 2011 |
4 other study(ies) available for methylprednisolone and celecoxib
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[Anaphylactic shock induced by celecoxib].
Topics: Anaphylaxis; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Drug Eruptions; Female; Fluid Therapy; Humans; Methylprednisolone; Middle Aged; Pyrazoles; Resuscitation; Risk Factors; Sulfonamides; Treatment Outcome | 2001 |
Methylprednisolone reduces pain and decreases knee swelling in the first 24 h after fast-track unicompartmental knee arthroplasty.
Topics: Acetaminophen; Aged; Aged, 80 and over; Amines; Analgesics; Anti-Inflammatory Agents; Arthroplasty, Replacement, Knee; Celecoxib; Cohort Studies; Cyclohexanecarboxylic Acids; Drug Therapy, Combination; Edema; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Knee Joint; Male; Methylprednisolone; Middle Aged; Osteoarthritis, Knee; Pain Measurement; Pain, Postoperative; Postoperative Complications; Postoperative Period; Preoperative Care; Prospective Studies; Range of Motion, Articular; Treatment Outcome; Walking | 2017 |